Skip to content

Extensive Circumferential Partial Thickness Sclerectomy in Nanophthalmic Eyes

Extensive Circumferential Partial Thickness Sclerectomy in Nanophthalmic Eyes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03748732
Enrollment
30
Registered
2018-11-21
Start date
2011-01-01
Completion date
2020-01-01
Last updated
2018-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nanophthalmos

Keywords

uveal effusion

Brief summary

Purpose: To describe an extensive scleral excision technique to treat or prevent uveal effusion in nanophthalmic eyes. Design: Prospective interventional case series. Methods: * Setting: Institutional. * Patient Population: Consecutive patients with nanophthalmos were operated on by one surgeon. * Intervention Procedure: A single, 90% thickness scleral window extending from immediately behind the extraocular muscle insertions to the vortex veins was performed for 3 and 1/4 quadrants as a circumferential strip. * Main Outcome Measure: Resolution or prevention of uveal effusion.

Detailed description

Surgical Technique All surgeries were performed under general anesthesia by one surgeon (AMM). Because the majority of the patients were young with narrow palpebral fissures and very deep set globes in small orbits, special surgical techniques were required. Lateral canthotomy was performed on all patients except for the first. Limbal 360o conjunctival peritomy was followed by securing of each rectus muscles with a modified muscle hook and 2-0 silk suture. Scleral dissection was performed from immediately behind to the muscle insertions posterior to the vortex veins. A 90% depth scleral window was excised over 3 and ¼ quadrants, excluding 3/4 of the superior temporal quadrant to avoid damaging the superior oblique muscle.

Interventions

PROCEDUREsclerectomy

scleral flap

Sponsors

Rafic Hariri University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

surgery

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

nanophthalmos -

Exclusion criteria

None \-

Design outcomes

Primary

MeasureTime frameDescription
resolution of uveal effusion1 monthdisappearence of uveal effusion by OCT

Countries

Lebanon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026